{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:01:42Z","timestamp":1764219702232,"version":"3.46.0"},"reference-count":36,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"unspecified","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,10,23]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This project explores the feasibility of setting up a neuropsychiatric de-identified database (DiD) and a Research Register (RR) to collect, analyse, monitor and systematically report clinical data for people with intellectual disabilities (PwIDs) and epilepsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>A multicentre project designed to collect de-identified data from clinical records at three adult ID specialist services in England and Wales and to develop an RR of PwID and epilepsy. Patients added to the DiD will be identified from patient clinic lists, clinic letters, in-house databases and electronic systems. Patients to be added to the RR will also be identified through attendance for regular review at clinic appointments. The collected data will be entered into the Research Electronic Data Capture (REDCap) database. Personal details of PwID and their consultees will also be collected from participants who consent to be on the RR. Around 600 PwID and epilepsy (200 per site) will be added to the DiD at the three sites, while around 45\u201360 participants (15\u201320 per site) are anticipated to be added to the RR. Data analysis will involve using descriptive statistics to summarise feasibility outcomes, such as screening and recruitment rates, as well as the completeness of the collected data. The characteristics of the participants (demographic, ID classification, clinical, epilepsy history and antiseizure medication) will be summarised descriptively. Progression will be assessed using the Red\/Amber\/Green stop-go criteria to determine if a national register should be created.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval (24\/NW\/0210) has been obtained from the Northwest-Haydock Research Ethics Committee and the University of Plymouth Faculty Research Ethics and Integrity Committee (reference no. 5284). The project is funded by Jazz Pharmaceuticals as an independent investigator-initiated support grant and, as such, has received independent peer review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT06780501\">NCT06780501<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-108869","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T03:50:22Z","timestamp":1764215422000},"page":"e108869","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Neuropsychiatric research databases for people with intellectual disabilities and epilepsy (REFINE): a feasibility study protocol"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct06780501","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0482-3218","authenticated-orcid":false,"given":"Crispin","family":"Musicha","sequence":"first","affiliation":[{"name":"Medical Statistics Group, University of Plymouth, Plymouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Neilens","sequence":"additional","affiliation":[{"name":"Peninsula Clinical Trials Unit, University of Plymouth, Plymouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Stanyard","sequence":"additional","affiliation":[{"name":"Peninsula Clinical Trials Unit, University of Plymouth, Plymouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5228-2623","authenticated-orcid":false,"given":"Victoria","family":"Allgar","sequence":"additional","affiliation":[{"name":"Medical Statistics Group, University of Plymouth, Plymouth, UK"},{"name":"Peninsula Clinical Trials Unit, University of Plymouth, Plymouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Lomax","sequence":"additional","affiliation":[{"name":"Medical Statistics Group, University of Plymouth, Plymouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Ashford","sequence":"additional","affiliation":[{"name":"Peninsula Clinical Trials Unit, University of Plymouth, Plymouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Hambly","sequence":"additional","affiliation":[{"name":"Peninsula Clinical Trials Unit, University of Plymouth, Plymouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paigan","family":"Aspinall","sequence":"additional","affiliation":[{"name":"Peninsula Clinical Trials Unit, University of Plymouth, Plymouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"O\u2019Shaughnessy","sequence":"additional","affiliation":[{"name":"Peninsula Clinical Trials Unit, University of Plymouth, Plymouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Rollinson","sequence":"additional","affiliation":[{"name":"Peninsula Clinical Trials Unit, University of Plymouth, Plymouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Lennard","sequence":"additional","affiliation":[{"name":"Cornwall Intellectual Disability Equitable Research (CIDER), Peninsula School of Medicine, University of Plymouth, Plymouth, UK"},{"name":"Cornwall Partnership NHS Foundation Trust, Bodmin, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Mclean","sequence":"additional","affiliation":[{"name":"Cornwall Intellectual Disability Equitable Research (CIDER), Peninsula School of Medicine, University of Plymouth, Plymouth, UK"},{"name":"Cornwall Partnership NHS Foundation Trust, Bodmin, UK"},{"name":"Royal Cornwall Hospitals NHS Trust, Truro, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Simpson","sequence":"additional","affiliation":[{"name":"National Centre for Mental Health, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Bowman","sequence":"additional","affiliation":[{"name":"Medical School, University of Exeter, Exeter, UK"},{"name":"NIHR Exeter Biomedical Research Centre, Exeter, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7004-3848","authenticated-orcid":false,"given":"Heather","family":"Angus-Leppan","sequence":"additional","affiliation":[{"name":"Royal Free Hampstead NHS Trust, London, UK"},{"name":"UCL Queen Square Institute of Neurology & St Mary\u2019s University, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance","family":"Watkins","sequence":"additional","affiliation":[{"name":"Cornwall Intellectual Disability Equitable Research (CIDER), Peninsula School of Medicine, University of Plymouth, Plymouth, UK"},{"name":"Swansea Bay UHB \u2013 Psychiatry of Learning Disability, Swansea, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Laugharne","sequence":"additional","affiliation":[{"name":"Cornwall Intellectual Disability Equitable Research (CIDER), Peninsula School of Medicine, University of Plymouth, Plymouth, UK"},{"name":"Cornwall Partnership NHS Foundation Trust, Bodmin, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Allard","sequence":"additional","affiliation":[{"name":"Cornwall Intellectual Disability Equitable Research (CIDER), Peninsula School of Medicine, University of Plymouth, Plymouth, UK"},{"name":"Cornwall Partnership NHS Foundation Trust, Bodmin, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1183-6933","authenticated-orcid":false,"given":"Rohit","family":"Shankar","sequence":"additional","affiliation":[{"name":"Cornwall Partnership NHS Foundation Trust, Bodmin, UK"},{"name":"Peninsula School of Medicine, University of Plymouth, Plymouth, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"2025112619501876000_15.11.e108869.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.03.016"},{"key":"2025112619501876000_15.11.e108869.2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/14656566.2019.1695780","article-title":"Quality improvement in the management of people with epilepsy and intellectual disability: the development of clinical guidance","volume":"21","author":"Watkins","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"2025112619501876000_15.11.e108869.3","unstructured":"Royal College of Psychiatrists 2017a management of epilepsy in adults with intellectual disability - CR203. 2017."},{"key":"2025112619501876000_15.11.e108869.4","unstructured":"Royal College of Psychiatrists 2017b, prescribing anti-epileptic drugs for people with epilepsy and intellectual disability - CR206. 2017."},{"key":"2025112619501876000_15.11.e108869.5","doi-asserted-by":"crossref","first-page":"108355","DOI":"10.1016\/j.yebeh.2021.108355","article-title":"People with epilepsy and intellectual disability: More than a sum of two conditions","volume":"124","author":"Snoeijen-Schouwenaars","year":"2021","journal-title":"Epilepsy & Behavior"},{"key":"2025112619501876000_15.11.e108869.6","unstructured":"Shankar R , Scheepers M , Liew A , et al . Step together integrating care for people with epilepsy and a learning disability. 2020."},{"key":"2025112619501876000_15.11.e108869.7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1684\/epd.2021.1366","article-title":"Epilepsy in adults with neurodevelopmental disability - what every neurologist should know","volume":"24","author":"Watkins","year":"2022","journal-title":"Epileptic Disord"},{"key":"2025112619501876000_15.11.e108869.8","unstructured":"(LeDeR programme, 2019) - the learning disability mortality review (LeDeR) programme. Annual report 2020. University of Bristol Norah Fry Centre for Disability Studies; 2021."},{"key":"2025112619501876000_15.11.e108869.9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.seizure.2014.10.001","article-title":"Does intellectual disability increase sudden unexpected death in epilepsy (SUDEP) risk?","volume":"25","author":"Young","year":"2015","journal-title":"Seizure"},{"key":"2025112619501876000_15.11.e108869.10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018292","article-title":"Prevalence of physical conditions and multimorbidity in a cohort of adults with intellectual disabilities with and without Down syndrome: cross-sectional study","volume":"8","author":"Kinnear","year":"2018","journal-title":"BMJ Open"},{"key":"2025112619501876000_15.11.e108869.11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324660"},{"key":"2025112619501876000_15.11.e108869.12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00225-2"},{"key":"2025112619501876000_15.11.e108869.13","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1212\/WNL.0000000000001948","article-title":"SUDEP: The death of nihilism","volume":"85","author":"Devinsky","year":"2015","journal-title":"Neurology (ECronicon)"},{"key":"2025112619501876000_15.11.e108869.14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.yebeh.2018.09.010","article-title":"Treatment of psychiatric comorbidities in patients with epilepsy and intellectual disabilities: Is there a role for the neurologist?","volume":"98","author":"Watkins","year":"2019","journal-title":"Epilepsy Behav"},{"key":"2025112619501876000_15.11.e108869.15","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/jnnp.74.11.1485","article-title":"Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables","volume":"74","author":"Espie","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025112619501876000_15.11.e108869.16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yebeh.2016.04.018","article-title":"A systematic review of neuropsychiatric comorbidities in patients with both epilepsy and intellectual disability","volume":"60","author":"van Ool","year":"2016","journal-title":"Epilepsy Behav"},{"key":"2025112619501876000_15.11.e108869.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2006.04.002"},{"key":"2025112619501876000_15.11.e108869.18","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1007\/s00415-021-10938-3","article-title":"Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study","volume":"269","author":"Sun","year":"2022","journal-title":"J Neurol"},{"key":"2025112619501876000_15.11.e108869.19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/epi4.12018","article-title":"Behavioral disorder in people with an intellectual disability and epilepsy: A report of the Intellectual Disability Task Force of the Neuropsychiatric Commission of ILAE","volume":"1","author":"Kerr","year":"2016","journal-title":"Epilepsia Open"},{"key":"2025112619501876000_15.11.e108869.20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0447.2005.00523.x","article-title":"Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder","volume":"2005","author":"Muzina","year":"2005","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"2025112619501876000_15.11.e108869.21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ridd.2010.10.013","article-title":"Epilepsy and intellectual disability: does epilepsy increase the likelihood of co-morbid psychopathology?","volume":"32","author":"Arshad","year":"2011","journal-title":"Res Dev Disabil"},{"key":"2025112619501876000_15.11.e108869.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198261","article-title":"Under representation of people with epilepsy and intellectual disability in research","volume":"13","author":"Shankar","year":"2018","journal-title":"PLoS One"},{"key":"2025112619501876000_15.11.e108869.23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/jir.13097","article-title":"The inclusion of adults with intellectual disabilities in health research - challenges, barriers and opportunities: a mixed-method study among stakeholders in England","volume":"68","author":"Bishop","year":"2024","journal-title":"J Intellect Disabil Res"},{"key":"2025112619501876000_15.11.e108869.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2020.07.018"},{"key":"2025112619501876000_15.11.e108869.25","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025112619501876000_15.11.e108869.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"2025112619501876000_15.11.e108869.27","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-13-S12-A15","article-title":"Research Electronic Data Capture (REDCap) - planning, collecting and managing data for clinical and translational research","volume":"13","author":"Harris","year":"2012","journal-title":"BMC Bioinformatics"},{"key":"2025112619501876000_15.11.e108869.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"2025112619501876000_15.11.e108869.29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.18556"},{"key":"2025112619501876000_15.11.e108869.30","unstructured":"StataCorp . Stata statistical software: release 19. College Station, TX: StataCorp LLCR, 2025."},{"key":"2025112619501876000_15.11.e108869.31","unstructured":"Core Team . R: a language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria; 2021. Available: https:\/\/www.R-project.org\/"},{"key":"2025112619501876000_15.11.e108869.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11701-6"},{"key":"2025112619501876000_15.11.e108869.33","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-019-3603-1","article-title":"Protection by exclusion? The (lack of) inclusion of adults who lack capacity to consent to research in clinical trials in the UK","volume":"20","author":"Shepherd","year":"2019","journal-title":"Trials"},{"key":"2025112619501876000_15.11.e108869.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209046"},{"key":"2025112619501876000_15.11.e108869.35","first-page":"185","article-title":"Establishing Patient Registries for Rare Diseases: Rationale and Challenges","volume":"34","author":"Boulanger","year":"2020","journal-title":"Pharmaceut Med"},{"key":"2025112619501876000_15.11.e108869.36","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1159E"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-108869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T03:50:29Z","timestamp":1764215429000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-108869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,26]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/bmjopen-2025-108869"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-108869","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}